ImageneBio, Inc. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
ImageneBio, Inc. (IMA) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One of $13.68 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue · last filed 2026-08-05
- 2026-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $13.68M.
- 2026-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $14.89M.
- 2025-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $26.41M.
- 2025-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $24.86M.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One |
|---|---|
| 2026-06-30 | $13.68M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $14.89M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $26.41M 10-K · filed 2026-03-10 |
| 2025-09-30 | $24.86M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $21.71M 10-Q · filed 2025-07-24 |
| 2025-03-31 | $52.83M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $70.64M 10-K · filed 2025-03-06 |
| 2024-09-30 | $78.69M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $72.85M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $60.80M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $22.23M 10-K · filed 2024-03-12 |
| 2023-09-30 | $89.28M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $85.07M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $111.62M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $79.65M 10-Q · filed 2023-11-09 |
| 2022-09-30 | $89.78M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $129.73M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $143.42M 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |